Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Bioimpedance Spectroscopy (BIS) for Use in a Renal Population

NCT05381961 is registered in ClinicalTrials.gov with ImpediMed Limited as lead sponsor.

NCT NCT05381961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05381961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Bioimpedance Spectroscopy (BIS) for Use in a Renal Population
Lead sponsor
ImpediMed Limited
Phase
Observational
Overall status
Unknown status
Start date
April 4, 2022
Completion date
September 30, 2023
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis, kidney failure, chronic, renal failure chronic